Literature DB >> 20504568

Changes in pituitary-adrenal activity affect the binding properties of striatal dopamine D-2 receptors but not their modulation by neurotensin and cholecystokinin-8.

G von Euler1, K Fuxe, S Tanganelli, U B Finnman, P Eneroth.   

Abstract

The effects of adrenalectomy were investigated on the binding properties of [ (3)H] N- propylnorapomorphine ([(3)H]NPA) binding sites in membrane preparations from the rat neostriatum. Adrenalectomy (1 week) was found to increase the K(D) value of [(3)H]NPA binding sites by 30 +/- 3%, without affecting the B(max) values. These effects were fully counteracted by replacement treatment with corticosterone (5 mg/kg, twice daily, 1 week, last injection given 2 h before killing). The ability of neurotensin and cholecystokinin-8 (sulphated) in vitro to increase the K(D) value of [(3)H]NPA binding sites was maintained also following adrenalectomy. The average increases were 16+/-7 and 21+/-6%, respectively. When added together the two peptides failed to increase the K(D) value any further. The B(max) values of [(3)H]NPA binding sites were not affected by either adrenalectomy or by the peptides. These results indicate a glucocorticoid regulation of the binding characteristics of dopamine D-2 receptors in the rat striatum. The mechanism mediating the effects of adrenalectomy may involve an altered expression or regulation of the D-2 receptor or of its connected G-proteins. Probably, it is different from the mechanism whereby the neuropeptides modulate the D-2 receptor, since the neuropeptide-induced modulation was also maintained following the changes induced by adrenalectomy.

Entities:  

Year:  1990        PMID: 20504568     DOI: 10.1016/0197-0186(90)90102-y

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  3 in total

1.  On the role of glucocorticoid receptors in brain plasticity.

Authors:  K Fuxe; R Diaz; A Cintra; M Bhatnagar; B Tinner; J A Gustafsson; S O Ogren; L F Agnati
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

2.  Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis.

Authors:  S Tanganelli; K Fuxe; G von Euler; P Eneroth; L F Agnati; U Ungerstedt
Journal:  J Neural Transm Gen Sect       Date:  1990

3.  Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.

Authors:  S Tanganelli; K Fuxe; G von Euler; L F Agnati; L Ferraro; U Ungerstedt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.